9 & 10 News
December 24, 2020
RIO DE JANEIRO Brazilian President Jair Bolsonaro has used his Christmas message to cast more doubt on a coronavirus vaccine purchased by one of the country’s states from the Chinese biopharmaceutical firm Sinovac.
In his live broadcast on social media Thursday, Bolsonaro said “the efficacy of that vaccine of Sao Paulo seems to be very low,” though he gave nothing specific.
Sao Paulo health authorities have not presented complete trial results a week after announcing that there were encouraging phase three studies on the shot’s effectiveness.
Brazil so far has no agreements to import vaccine made by American companies Pfizer or Moderna, which have been approved by U.S. and other nations. It has a deal to secure up to 100 million doses of the potential vaccine produced by AstraZeneca.
Read more about Chinese Sinovac s CoronaVac vaccine 91.25% effective, says Turkish official on Business Standard. An experimental Covid-19 vaccine developed by Chinese biopharmaceutical company Sinovac is 91.25 per cent effective, a Turkish health official said on Thursday
NEW YORK The number of passengers screened for flights in the U.S. topped nearly 1.2 million Wednesday for the first time since the coronavirus pandemic outbreak, but it’s still about 38.5% below the same Wednesday last year, by far the smallest percentage decline since March. The Transportation Security Administration said Wednesday's tally of 1.19 million was the most since mid-March. It’s the third straight daily gain. On the same weekday a year ago, 1.94 million passengers were screened. However, that was Christmas 2019 when travel was lighter than normal. On several days in early
The Latest: Turkey to receive 3M CoronaVac vaccine dose accesswdun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from accesswdun.com Daily Mail and Mail on Sunday newspapers.
2020/12/25 02:00 ISTANBUL (AP) An experimental COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac is 91.25% effective, a Turkish health official said on Thursday. Dr. Serhat Unal, an infectious disease expert serving on Turkey’s medical board, said the finding is based on early results of late-stage trials in the country and added that the vaccine is safe. CoronaVac is a so-called inactivated vaccine developed by Sinovac Biotech. Unal announced the initial results following randomized trials involving 7,371 volunteers. Turkey’s Health Minister Fahrettin Koca said in the press conference the results were the first to be announced for CoronaVac. Media reports said Sinovac delayed announcing results from late-stage trials until January to consolidate data from other countries where trials took place. The efficacy rate announced by Turkey could not be immediately verified independently.